These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 22773547

  • 1. A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity.
    Oancea I, Png CW, Das I, Lourie R, Winkler IG, Eri R, Subramaniam N, Jinnah HA, McWhinney BC, Levesque JP, McGuckin MA, Duley JA, Florin TH.
    Gut; 2013 Apr; 62(4):594-605. PubMed ID: 22773547
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic drug monitoring of 6-thioguanine nucleotides in inflammatory bowel disease: interest and limits].
    Jourdil N, Fonrose X, Boulieu R, Stanke-Labesque F, Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010 Apr; 65(3):177-86. PubMed ID: 20699068
    [Abstract] [Full Text] [Related]

  • 3. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L, Richards S, Cartwright CS, Mitchell C, Lilleyman JS, Vora A, UK MRC/NCRI Childhood Leukaemia Working Party.
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [Abstract] [Full Text] [Related]

  • 4. Tissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice.
    Aubrecht J, Goad ME, Schiestl RH.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1102-8. PubMed ID: 9262380
    [Abstract] [Full Text] [Related]

  • 5. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy.
    Cuffari C, Seidman EG, Latour S, Théorêt Y.
    Can J Physiol Pharmacol; 1996 May; 74(5):580-5. PubMed ID: 8884023
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
    Toksvang LN, Schmidt MS, Arup S, Larsen RH, Frandsen TL, Schmiegelow K, Rank CU.
    PLoS One; 2019 May; 14(5):e0212157. PubMed ID: 31125338
    [Abstract] [Full Text] [Related]

  • 8. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.
    Morgan CJ, Chawdry RN, Smith AR, Siravo-Sagraves G, Trewyn RW.
    Cancer Res; 1994 Oct 15; 54(20):5387-93. PubMed ID: 7923170
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow.
    Hacke K, Szakmary A, Cuddihy AR, Rozengurt N, Lemp NA, Aubrecht J, Lawson GW, Rao NP, Crooks GM, Schiestl RH, Kasahara N.
    Exp Hematol; 2012 Jan 15; 40(1):3-13.e3. PubMed ID: 22001673
    [Abstract] [Full Text] [Related]

  • 11. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar 15; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 12. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY, Devlin SM, Mirocha JM, Papadakis KA.
    Dig Liver Dis; 2008 Jun 15; 40(6):425-32. PubMed ID: 18304898
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood.
    Erb N, Haverland U, Harms DO, Escherich G, Janka-Schaub G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct 25; 796(1):87-94. PubMed ID: 14552819
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease.
    Romagosa R, Kerdel F, Shah N.
    J Am Acad Dermatol; 2002 Dec 25; 47(6):970-2; author reply 972. PubMed ID: 12451396
    [No Abstract] [Full Text] [Related]

  • 17. Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide.
    Inamochi H, Higashigawa M, Shimono Y, Nagata T, Cao DC, Mao XY, M'soka T, Hori H, Kawasaki H, Sakurai M.
    J Exp Clin Cancer Res; 1999 Sep 25; 18(3):417-24. PubMed ID: 10606189
    [Abstract] [Full Text] [Related]

  • 18. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
    Ezzat T, van den Broek MA, Davies N, Dejong CH, Bast A, Malagó M, Dhar DK, Olde Damink SW.
    J Surg Oncol; 2012 Jul 01; 106(1):72-8. PubMed ID: 22287334
    [Abstract] [Full Text] [Related]

  • 19. Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.
    Chen Z, Huo JR, Yang L, Zhu HY.
    J Gastroenterol Hepatol; 2011 Jun 01; 26(6):1016-21. PubMed ID: 21251065
    [Abstract] [Full Text] [Related]

  • 20. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L, Narjoz C, Beaune P, Loriot MA, Roblin X.
    Aliment Pharmacol Ther; 2012 Jan 01; 35(1):15-36. PubMed ID: 22050052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.